NanosVet sells $8.3M to build fast-dissolving pet medicine

NanosVet has 17 investors behind an $8.6M offering, while its catalog lists one product for sale.

By · Published

Primary source: SEC

Why it matters

The $8.3M gives Andrew Green room to turn one pet-wellness strip into a veterinary drug-delivery platform. Clinical evidence and repeatable manufacturing will determine whether NanoMelt earns that label.

A small, advanced-looking, fast-dissolving pet medicine tablet resting on a clean, reflective white laboratory counter.

Andrew Green, founder and CEO of NanosVet, has sold $8.3 million of securities to finance a pet-health platform built around fast-dissolving oral strips, according to a Form D filed with the SEC.…

Reader comments

Conversation for this story loads after sign-in.